Streetbeat News

Products Services

ATNF

180 Life Sciences has been granted a European patent for treating Dupuytren's Disease using a TNF Receptor 2 antagonist. This development could enhance their intellectual property portfolio and potentially lead to new treatment options.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:58 pm

DELL

HPQ

MSFT

XRX

HP Inc reported a mixed fiscal third quarter with a 2.4% revenue increase, driven by corporate PC purchases and Microsoft's end of Windows 10 support. However, weak short-term guidance and a decline in the printing segment led to a cut in full-year profit outlook. HP's stock rose 4% following the report.

Portfolio Pulse from Upwallstreet

September 04, 2024 | 7:53 pm

UBSFY

Ubisoft's recent release, Star Wars Outlaws, has underperformed in sales, leading to a significant drop in the company's share price. Analyst Daniel Kerven has lowered sales forecasts, and the game's development costs were notably high. Ubisoft's financial health now hinges on the success of its upcoming release, Assassin's Creed Shadows.

Portfolio Pulse from Franca Quarneti

September 04, 2024 | 7:51 pm

FFIE

Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares surged over 50% following the launch of an Innovative Co-Creation Campaign. This initiative allows users and investors to participate in strategic decision-making for FF's second brand and products, with results to be unveiled on September 19.

Portfolio Pulse from Vaishali Prayag

September 04, 2024 | 7:51 pm

FFIE

Faraday Future Intelligent Electric shares rose as the company launched its 'Your Vision, Our Drive: Co-Creating the Future of Affordable AI EVs' campaign.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:41 pm

GTLS

Chart Industries anticipates significant opportunities in data centers and LNG projects for the second half of 2024 and 2025, projecting a 10% revenue growth in 2025 compared to 2024.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:04 pm

MRK

Merck has received Canadian authorization for WINREVAIR (Sotatercept), the first activin signaling inhibitor therapy for treating pulmonary arterial hypertension in adults. This marks a significant milestone for Merck in expanding its product offerings in the cardiovascular space.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 7:01 pm

INM

InMed Pharmaceuticals is experiencing increased trading volume following a positive market response to its cannabinoid analog INM-901, which is being developed for Alzheimer's treatment.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 6:59 pm

AVGO

Broadcom Inc (NASDAQ:AVGO) is set to report its Q3 earnings, with analysts focusing on its AI revenue potential. The company has a strong track record of beating estimates and is expected to continue this trend. Broadcom's stock has risen 42% YTD, and its AI segment is seen as a key growth driver. Analysts are particularly interested in the company's guidance and AI-related developments.

Portfolio Pulse from Chris Katje

September 04, 2024 | 6:57 pm

TSLA

Tesla shares are trading higher following the introduction of a $3,000 winter tire package for the Cybertruck, addressing performance concerns in snowy conditions. This move aligns with Tesla's production goals and market expansion efforts.

Portfolio Pulse from Vaishali Prayag

September 04, 2024 | 6:56 pm